From January 19, 2024 to March 31, 2024, the company has repurchased 1,496,000 shares, representing 0.32% for CNY 84.75 million. With this, the company has completed the repurchase of 1,496,000 shares, representing 0.32% for CNY 84.75 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.61 CNY | -3.04% | +3.29% | -36.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.69% | 2.63B | |
-17.21% | 8.46B | |
+44.64% | 3.88B | |
-8.06% | 2.45B | |
-9.64% | 2.31B | |
-6.30% | 1.99B | |
-17.41% | 1.61B | |
-37.21% | 1.3B | |
+5.14% | 1.09B | |
-20.20% | 906M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.